Marcos-Vidal José Miguel, González Rafael, Merino María, Higuera Eva, García Cristina
Department of Anesthesiology and Critical Care, Universitary Hospital of Leon, 24071 Leon, Spain.
J Pers Med. 2023 Nov 24;13(12):1641. doi: 10.3390/jpm13121641.
This article looks at the challenges of sedoanalgesia for sepsis patients, and argues for a personalised approach. Sedation is a necessary part of treatment for patients in intensive care to reduce stress and anxiety and improve long-term prognoses. Sepsis patients present particular difficulties as they are at increased risk of a wide range of complications, such as multiple organ failure, neurological dysfunction, septic shock, ARDS, abdominal compartment syndrome, vasoplegic syndrome, and myocardial dysfunction. The development of any one of these complications can cause the patient's rapid deterioration, and each has distinct implications in terms of appropriate and safe forms of sedation. In this way, the present article reviews the sedative and analgesic drugs commonly used in the ICU and, placing special emphasis on their strategic administration in sepsis patients, develops a set of proposals for sedoanalgesia aimed at improving outcomes for this group of patients. These proposals represent a move away from simplistic approaches like avoiding benzodiazepines to more "objective-guided sedation" that accounts for a patient's principal pathology, as well as any comorbidities, and takes full advantage of the therapeutic arsenal currently available to achieve personalised, patient-centred treatment goals.
本文探讨了脓毒症患者镇静镇痛的挑战,并主张采用个性化方法。镇静是重症监护患者治疗的必要组成部分,以减轻压力和焦虑并改善长期预后。脓毒症患者存在特殊困难,因为他们发生多种并发症的风险增加,如多器官功能衰竭、神经功能障碍、感染性休克、急性呼吸窘迫综合征、腹腔间隔室综合征、血管麻痹综合征和心肌功能障碍。这些并发症中的任何一种的发生都可能导致患者迅速恶化,并且每种并发症在适当和安全的镇静形式方面都有不同的影响。通过这种方式,本文回顾了重症监护病房常用的镇静和镇痛药物,并特别强调它们在脓毒症患者中的合理使用,制定了一套镇静镇痛建议,旨在改善这组患者的治疗效果。这些建议代表了从避免使用苯二氮䓬类药物等简单方法转向更“目标导向镇静”的转变,这种方法考虑了患者的主要病理状况以及任何合并症,并充分利用目前可用的治疗手段来实现个性化的、以患者为中心的治疗目标。